Xuhong Hou
Overview
Explore the profile of Xuhong Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Sun D, Targher G, Byrne C, Lee B, Hamaguchi M, et al.
eGastroenterology
. 2025 Feb;
1(1):e100005.
PMID: 39944252
Background And Aim: Metabolic dysfunction-associated fatty liver disease (MAFLD) is an alternative description and classification of non-alcoholic fatty liver disease (NAFLD) that may have better utility than NAFLD in clinical...
2.
Liu D, Yu S, Zhang Y, Li Q, Kang P, Wang L, et al.
Diabetes Obes Metab
. 2025 Feb;
27(4):2232-2241.
PMID: 39895483
Aims: Fibroblast growth factor (FGF) 23 is a bone-derived phosphaturic hormone that participates in the regulation of mineral metabolism and the development of chronic kidney disease. This study aimed to...
3.
Jia W, Yu R, Wang L, Zhu D, Guo L, Weng J, et al.
Lancet Reg Health West Pac
. 2025 Jan;
55:101463.
PMID: 39882253
Background: To date, comprehensive data on the distribution of chronic kidney disease (CKD), the most prevalent comorbidity in diabetes, among Chinese adults with diabetes is lacking. Additionally, research gaps exist...
4.
Wang J, Yan D, Wang S, Zhao A, Hou X, Zheng X, et al.
Metabolites
. 2025 Jan;
15(1).
PMID: 39852408
: This study aimed to capture the early metabolic changes before osteoporosis occurs and identify metabolomic biomarkers at the osteopenia stage for the early prevention of osteoporosis. : Metabolomic data...
5.
Chen H, Chen S, Liu D, Liang Y, Li H, Bao Y, et al.
Cell Rep Med
. 2025 Jan;
6(1):101884.
PMID: 39765230
The effectiveness of established biomarkers for non-alcoholic fatty liver disease (NAFLD) within the updated framework of steatotic liver disease (SLD) remains uncertain. This cohort study examines the association of four...
6.
Dai L, Sheng B, Chen T, Wu Q, Liu R, Cai C, et al.
Nat Med
. 2024 Jan;
30(2):584-594.
PMID: 38177850
Diabetic retinopathy (DR) is the leading cause of preventable blindness worldwide. The risk of DR progression is highly variable among different individuals, making it difficult to predict risk and personalize...
7.
Chen H, Liu Y, Liu D, Liang Y, Zhu Z, Dong K, et al.
J Mol Cell Biol
. 2023 Dec;
15(11).
PMID: 38037475
Obesity is closely related to non-alcoholic fatty liver disease (NAFLD). Although sex differences in body fat distribution have been well demonstrated, little is known about the sex-specific associations between adipose...
8.
Guan Z, Li H, Liu R, Cai C, Liu Y, Li J, et al.
Cell Rep Med
. 2023 Oct;
4(10):101213.
PMID: 37788667
The increasing prevalence of diabetes, high avoidable morbidity and mortality due to diabetes and diabetic complications, and related substantial economic burden make diabetes a significant health challenge worldwide. A shortage...
9.
Hou X, Wang L, Zhu D, Guo L, Weng J, Zhang M, et al.
Nat Commun
. 2023 Jul;
14(1):4296.
PMID: 37463878
The current epidemic status of diabetic retinopathy in China is unclear. A national prevalence survey of diabetic complications was conducted. 50,564 participants with gradable non-mydriatic fundus photographs were enrolled. The...
10.
Liang Y, Chen P, Chen S, Liu D, Jiang F, Zhu Z, et al.
JHEP Rep
. 2023 Jul;
5(7):100730.
PMID: 37425213
Background & Aims: No prospective studies have examined the association between thigh subcutaneous fat distribution and non-alcoholic fatty liver disease (NAFLD). We investigated the associations of thigh subcutaneous fat distribution...